S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study
Abstract Background and Objectives S-1-based regimens have been shown to be as effective as other fluoropyrimidine-based regimens with a better safety profile in patients with advanced esophagogastric adenocarcinoma. However, real-world data on S-1 in European patients with advanced esophagogastric...
Saved in:
Main Author: | Marino Venerito (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma
by: Emer Lynch, et al.
Published: (2023) -
Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
by: Seyed Amir Aledavood, et al.
Published: (2021) -
Renal cell carcinoma metastasizing to adenocarcinoma of esophagogastric junction: A rare case of tumor-to-tumor metastasis
by: Renu Sukumaran, et al.
Published: (2012) -
Esophagogastric fistula complicating Nissen fundoplication
by: Marcel Tafen, et al.
Published: (2016) -
Cervical metastasis of esophagogastric junction cancer
by: Zhiqiang Cai, et al.
Published: (2012)